Answers are grounded in this paper and cite their sources.
Retrospective cohort study examines vasopressin's role in hyponatremia during MAP augmentation in acute spinal cord injury, suggesting a need for further exploration.
Background MAP augmentation is a guideline-recommended intervention in acute spinal cord injury (SCI), and vasopressin can be used to achieve mean arterial pressure (MAP) goals. Vasopressin could contribute to hyponatremia in SCI, but this relationship is poorly described.
No takes yet. Share an insight, caveat, or question.
Corello et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: